Spark Therapeutics, Inc. (ONCE) Stock Price,
News & Historical Data - TheStreet ([original](https://www.thestreet.com/quote/ONCE)) ([raw](?raw))[ ONCE ]
NewsProfileAnalyst Coverage5 Yr. FinancialsDividendsEarningsPrice HistoryEventsInsiders
Spark Therapeutics, Inc. News
Mar 16, 2022 10:23 PM EDT
Novartis and Roche Have Expensive Drugs That Scare Away Competitors
A brief snapshot of some medical breakthroughs that are among the costliest in the world.
Jul 8, 2019 11:10 AM EDT
Sangamo Shares Soar as Hemophilia Drug Shows Promise
Sangamo's stock price is surging after a pair of patients reported no bleeding events for as long as 24 weeks following treatment following investigational SB-525 gene therapy for severe hemophilia A.
Jun 10, 2019 11:01 AM EDT
Spark Therapeutics' Shares Misfire on Roche Acquisition Delay
Shares of Spark Therapeutics slide amid a second regulatory-related delay of its $4.3 billion deal with Swiss pharmaceuticals group Roche Holdings AG.
Apr 3, 2019 9:43 AM EDT
Roche Buys More Time in $4.3B Offer for Spark Therapeutics
Roche plans to regroup on its $4.3 billion offer to buy Spark Therapeutics after failing to win enough Spark shareholder votes, or receiving U.S. regulatory approval.
Mar 13, 2019 1:20 PM EDT
Trading Roku Stock as Downgrades Sap Its Run to New Highs
Roku was hit with a pair of downgrades on Wednesday
Feb 25, 2019 8:57 PM EST
Win, With or Without China: Cramer's 'Mad Money' Recap
Jim Cramer asks whether there aren't enough good things happening that we can sustain an advance without a China deal.
Feb 25, 2019 4:19 PM EST
3 Things to Know at Market Close: ETF Inflows, Spark Therapeutics, Palo Alto
ETFs could see big inflows again and Sparks stock soars; these are among the important market items today.
Feb 25, 2019 4:06 PM EST
Dow Closes Modestly Higher After Trump Extends China Tariff Deadline
The Dow Jones Industrial Average rose modestly Monday after Donald Trump said he will delay increasing tariffs on China-made goods.
Feb 25, 2019 11:37 AM EST
Spark Therapeutics Rockets as Roche Pays $4.3 Billion for Gene Therapy Experts
Spark Therapeutics shares more than double Monday after the gene therapy specialist agreed to a $4.3 billion takeover by Switzerland-based Roche Holding, the world's biggest maker of cancer treatments.
Feb 25, 2019 8:05 AM EST
Trade Talks, Spark, Buffett, Kraft Heinz, 'Green Book' - 5 Things You Must Know
U.S. stock futures rise after Donald Trump says he will delay increasing tariffs on China-made goods; Swiss drug giant Roche to buy Spark Therapeutics for about $4.8 billion; Warren Buffett wants to make an 'elephant-sized acquisition'; Kraft Heinz reportedly reviewing options for Maxwell House.
Feb 25, 2019 7:37 AM EST
Stocks Gain, China Surges, as Trump Delays Tariffs Amid Trade Talk Progress
StocksGlobal stocks traded higher Monday after President Donald Trump said he would delay the increase of tariffs on China-made goods, set to kick-in on March 1, following "substantial progress" over two weeks of trade talks between Washington and Beijing.
Feb 25, 2019 1:28 AM EST
Roche to Buy Spark for $4.8 Billion
The price is nearly 3billionoverSpark′smarketcapof3 billion over Spark's market cap of 3billionoverSpark′smarketcapof1.95 billion as of Friday's close. Deal is slated to close in the second quarter of 2019.
Feb 24, 2019 12:45 PM EST
Roche Aims to Buy Spark for $5 Billion: Wall Street Journal
Predicted price would be nearly $3 billion over Spark's market cap as of Friday's close, but Roche spokesman claims report is 'market rumor.'
Aug 13, 2018 8:00 AM EDT
3 Biotech Stock Favorites to Bet on Today: Top Analysts
Follow the experts. These biotech stocks have Wall Street's best analysts getting bullish.
Dec 13, 2017 11:34 AM EST
7 Winners and Losers From Biggest Biotech Conference of 2017
Here are how some of the conference presenters are performing on the market Wednesday
Dec 11, 2017 12:23 PM EST
Bluebird Bio Becoming Household Name With This Promising Cancer Treatment
Bluebird Bio stock is flying higher by 20% Monday, following an update of its promising cancer treatments, Jim Cramer said.
Oct 12, 2017 7:26 PM EDT
FDA Advisory Committee Greenlights First Gene Therapy For Inherited Disorder
Spark Therapeutics gains gene therapy advisory OK for treatment restoring some sight for patients facing eventual blindness.
Aug 2, 2017 11:17 AM EDT
Illumina Shares Jump on Better-Than-Expected Second-Quarter Numbers
Illumina, Spark Therapeutics and Endo International were among the biotech stock movers in premarket trading on Aug. 2.
Jul 14, 2017 4:11 PM EDT
Celgene, Vertex and Spark Among Jefferies' Top Biotech Picks
Top names.
Dec 5, 2016 1:11 PM EST
Blood Work: A Few Biotech Thoughts From Sunny San Diego and the ASH 2016 Meeting
I spent the weekend with thousands of blood disease researchers. This is what happened.
Spark Therapeutics, Inc. News from TheStreet Pro
Feb 25, 2019 3:34 PM EST
Jim Cramer: How to Win Now, With or Without China
If we can advance without China then who the heck knows where we can go with it.
Feb 25, 2019 8:33 AM EST
Roche Deal for Spark Therapeutics Shows Biotech M&A Spark Hasn't Died
Acquisition deals for biotech companies at the start of 2019 are giving the sector a nice boost; here are other names that could be merger candidates.
Dec 11, 2017 9:40 AM EST
Blueprint Medicines and Bluebird Bio Soar on ASH Announcements -- Biotech Movers
Blueprint unveiled new data from its ongoing Phase 1 study of avapritinib in advanced systemic mastocytosis at the 59th American Society of Hematology Annual Meeting.
Feb 21, 2017 3:57 AM EST
We May Be Back to Maximum Overbought by Thursday
Breadth has a small window to improve from the poor and lagging action we saw last week.
Breaking News
Sep 25, 2024 10:58 AM EDT
Analyst resets Tesla stock price target ahead of Q3 deliveries
Tesla will report its third-quarter delivery details early next week.
Sep 24, 2024 5:47 PM EDT
Bankrupt clothing retail chain liquidates, closes all stores
The casual clothing chain will liquidate and shutter its stores and transition to a wholesale and e-commerce business model.
Sep 25, 2024 1:13 PM EDT
Stock Market Today: Stocks lower as rate cut bets put growth in focus
Stocks are trading near record highs Wednesday, but the key driver of rate cuts is weighing on risk sentiment.
Sep 24, 2024 7:17 PM EDT
Analysts adjust Corona beer parent company stock price target on sales
Here's what could happen next to shares of Constellation Brands.